Skip to main content
Download PDF

Proteomic and genomic technologies for biomarker discovery

Where are the biomarkers?

Clinical Proteomics volume 2, pages 5–11 (2006)Cite this article

References

  1. Etzioni, R., Urban, N., Ramsey, S., et al. (2003) The case for early detection. Nat. Rev. Cancer 3, 243–252.

    Article  PubMed  CAS  Google Scholar 

  2. Bast, R. C., Jr., Klug, T. L., St. John, E., et al. (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N. Engl. J. Med. 309, 883–887.

    Article  PubMed  Google Scholar 

  3. Celis, A., Rasmussen, H. H., Celis, P., et al. (1999) Short-term culturing of low-grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activities. Electrophoresis 20, 355–361.

    Article  PubMed  CAS  Google Scholar 

  4. Kageyama, S., Isono, T., Iwaki, H., et al. (2004) Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine. Clin. Chem. 50, 857–866.

    Article  PubMed  CAS  Google Scholar 

  5. Wang, X., Yu, J., Sreekumar, A., et al. (2005) Autoantibody signatures in prostate cancer. N. Engl. J. Med. 353, 1224–1235.

    Article  PubMed  CAS  Google Scholar 

  6. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., et al. (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359, 572–577.

    Article  PubMed  CAS  Google Scholar 

  7. Caprioli, R. M. (2005) Deciphering protein molecular signatures in cancer tissues to aid in diagnosis, prognosis, and therapy. Cancer Res. 65, 10,642–10,645.

    Article  CAS  Google Scholar 

  8. Yanagisawa, K., Shyr, Y., Xu, B. J., et al. (2003) Proteomic patterns of tumor subsets in non-small-cell lung cancer. Lancet 362, 433–439.

    Article  PubMed  CAS  Google Scholar 

  9. Martin, D. B., Gifford, D. R., Wright, M. E., et al. (2004) Quantitative proteomic analysis of proteins released by neoplastic prostate epithelium. Cancer Res. 64, 347–355.

    Article  PubMed  CAS  Google Scholar 

  10. Perou, C. M., Sorlie, T., Eisen, M. B., et al. (2000) Molecular portraits of human breast tumors. Nature 406, 747–752.

    Article  PubMed  CAS  Google Scholar 

  11. Alizadeh, A. A., Ross, D. T., Perous, C. M., and van de Rijn, M. (2001) Towards a novel classification of human malignancies based on gene expression patterns. J. Pathol. 195, 41–52.

    Article  PubMed  CAS  Google Scholar 

  12. Weigelt, B., Hu, Z., He, X., et al. (2005) Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res. 65, 9144–9158.

    Article  Google Scholar 

  13. Alizadeh, A. A., Eisen, M. B., Davis, R. E., et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511.

    Article  PubMed  CAS  Google Scholar 

  14. Rosenwald, A., Wright, G., Chan, W. C., et al. (2002) Lymphoma/leukemia molecular profiling project: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 346, 1937–1947.

    Article  PubMed  Google Scholar 

  15. Bhattacharjee, A., Richards, W. G., Staunton, J., et al. (2001) Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA 98, 13,790–13,795.

    Article  CAS  Google Scholar 

  16. Ramaswamy, S., Ross, K. N., Lander, E. S., and Golub, T. R. (2003) A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49–54.

    Article  PubMed  CAS  Google Scholar 

  17. Pemeroy, S. L., Tamayo, P., Gaasenbeek, M., et al. (2002) Prediction of central nervous system embryonal tumor outcome based on gene expression. Nature 415, 436–442.

    Article  CAS  Google Scholar 

  18. Iizuka, N., Hammoto, Y., and Oka, M. (2004) Predicting individual outcomes in hepatocellular carcinoma. Lancet 364, 1837–1839.

    Article  PubMed  Google Scholar 

  19. van de Vijver, M. J., He, Y. D., van't Veer, I. J., et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999–2009.

    Article  PubMed  Google Scholar 

  20. van't Veer, I. J. and Weigelt, B. (2003) Road map to metastasis. Nat. Med. 9, 999–1000.

    Article  CAS  Google Scholar 

  21. Lossos, I. S., Czerwinski, D. K., Alizadeh, A. A., et al. (2004) Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N. Engl. J. Med. 350, 1828–1837.

    Article  PubMed  CAS  Google Scholar 

  22. Cronin, M., Pho, M., Dutta, D., et al. (2004) Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. Am. J. Pathol. 164, 35–42.

    PubMed  CAS  Google Scholar 

  23. Bast, R. C., Jr., Ravdin, P., Hayes, D. F., et al. (2000) Update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J. Clin. Oncol. 19, 1865–1878.

    Google Scholar 

  24. Finne, P., Finne, R., Auvinen, A., et al. (2000) Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network. Urology 56, 418–422.

    Article  PubMed  CAS  Google Scholar 

  25. Stephan, C., Cammann, H., Semjonow, A., et al. (2002) Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies. Clin. Chem. 48, 1279–1287.

    PubMed  CAS  Google Scholar 

  26. Diamandis, E. P. (2003) Point: proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? Clin. Chem. 49, 1272–1275.

    Article  PubMed  CAS  Google Scholar 

  27. Diamandis, E. P. (2003) Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J. Natl. Cancer Inst. 96, 353–356.

    Google Scholar 

  28. Karsan, A., Eigl, B. J., Fibotte, S., et al. (2005) Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis. Clin. Chem. 51, 1525–1528.

    Article  PubMed  CAS  Google Scholar 

  29. Banks, R. E., Stanley, A. J., Cairns, D. A., et al. (2005) Influences of blood sample processing on low-molecular-weight-proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. Clin. Chem. 51, 1637–1649.

    Article  PubMed  CAS  Google Scholar 

  30. Baggerly, K. A., Morris, J. S., Edmonson, S. R., and Coombes, K. R. (2005) Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J. Natl. Cancer Inst. 97, 307–309.

    Article  PubMed  CAS  Google Scholar 

  31. Ransohoff, D. F. (2005) Lessons from controversy: ovarian cancer screening and serum proteomics. J. Natl. Cancer Inst. 97, 315–319.

    Article  PubMed  CAS  Google Scholar 

  32. Elias, J. E., Haas, W., Faherty, B. K., and Gygi, S. P. (2005) Comparative evaluation of mass spectrometry platforms used in large-scale proteomics investigations. Nat. Methods 2, 667–675.

    Article  PubMed  CAS  Google Scholar 

  33. Michiels, S., Koscielny, S., and Hill, C. (2005) Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 365, 488–492.

    Article  PubMed  CAS  Google Scholar 

  34. Ioannidis, J. P. (2005) Microarrays and molecular research: noise discovery? Lancet 365, 454–455.

    PubMed  Google Scholar 

  35. Branca, M. A. (2005) Omic diagnostics trip up on way to clinic. Nat Biotechnol. 23, 769.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada

    Vathany Kulasingam & Eleftherios P. Diamandis

  2. Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Ave., M5G 1X5, Toronto, ON, Canada

    Vathany Kulasingam & Eleftherios P. Diamandis

Authors
  1. Vathany Kulasingam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eleftherios P. Diamandis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eleftherios P. Diamandis.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Kulasingam, V., Diamandis, E.P. Proteomic and genomic technologies for biomarker discovery. Clin Proteom 2, 5–11 (2006). https://doi.org/10.1385/CP:2:1:5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/CP:2:1:5

Clinical Proteomics

ISSN: 1559-0275